| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Walter L Krebs last filed a Form 4 in August 2019, as Director at CHE. Walter L Krebs's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 9,318 shares of CHE. The CHE filings lean toward selling, a net 7,910 shares.
Walter L Krebs has 7 Form 4 filings on record from May 2015 to August 2019, all as Director at Chemed (CHE), 2015–2019.
The 7 reported transactions were 5 stock awards and 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $1.9M.
The largest open-market sale was 2,910 shares of CHE at an average $430.41 on August 23, 2019, about $1.3M.
Shares as reported in the last Form 4 for each company; the most recent is from August 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.